Stock ANCN ANCHIANO THERAPEUTICS LTD
Add to a list
To use this feature you must be a member
Log inSign up

News Anchiano Therapeutics Ltd TEL AVIV STOCK EXCHANGE

Equities

ANCN

IL0011267882

Delayed TEL AVIV STOCK EXCHANGE
Other stock markets
 09:24:34 2019-06-16 am EDT 		5-day change 1st Jan Change
290.7 ILa -.--% Intraday chart for Anchiano Therapeutics Ltd -6.23% -68.96%
2021 DJ Industrial : Wall Street Narrowly Mixed; Data, Fed Rate Meeting in Focus MT
2021 Anchiano Therapeutics : Shareholders OK Pending Chemomab Merger MT

Summary

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
ANCHIANO THERAPEUTICS LTD. : Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Unregistered Sale of Equity Securities, Material Modification to Rights of Security Holders, Changes in Control or Registrant, Change in Directors or Principal Officers, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders, Other Events, Financial Statements and Exhibits (form 8-K)
AQ
DJ Industrial : Wall Street Narrowly Mixed; Data, Fed Rate Meeting in Focus
MT
Anchiano Therapeutics : Shareholders OK Pending Chemomab Merger
MT
Anchiano Therapeutics Ltd.(NasdaqCM:ANCN) dropped from NASDAQ Composite Index
CI
ChemomAb Ltd. completed the acquisition of Anchiano Therapeutics Ltd. in a reverse merger transaction.
CI
Anchiano Announces Shareholder Approval of the Merger with Chemomab and Prices $45.5M Private Financing
GL
ANCHIANO THERAPEUTICS LTD. : Other Events (form 8-K)
AQ
ANCHIANO THERAPEUTICS : Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-K)
AQ
Anchiano Therapeutics Ltd. Reports Earnings Results for the Full Year Ended December 31, 2020
CI
Anchiano Therapeutics Ltd. Auditor Raises 'Going Concern' Doubt
CI
ANCHIANO THERAPEUTICS LTD. : Other Events (form 8-K)
AQ
ANCHIANO INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Anchiano Therapeutics Ltd. - ANCN
BU
ANCHIANO THERAPEUTICS LTD. : Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits (form 8-K)
AQ
Anchiano Therapeutics : Chemomab Plan Merger to Advance Treatment for Fibrosis-Related Diseases
MT
Anchiano Therapeutics : and Chemomab Announce Entry Into Definitive Merger Agreement
AQ
Anchiano Therapeutics Ltd. and Chemomab Ltd. Announce Executive Appointments
CI
ChemomAb Ltd. entered into letter of intent to acquire Anchiano Therapeutics Ltd. for for $27.2 million in a reverse merger transaction.
CI
Anchiano Therapeutics Ltd. Reports Earnings Results for the Third Quarter Ended September 30, 2020
CI
ANCHIANO THERAPEUTICS : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)
AQ
ANCHIANO THERAPEUTICS LTD. : Change in Directors or Principal Officers (form 8-K)
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ANCN Stock
  4. ANCN Stock
  5. News Anchiano Therapeutics Ltd